Pereira Lab
@cellreprolab.bsky.social
Cell Reprogramming in Hematopoiesis and Immunity, Lund University, Sweden. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for Pereira lab). https://pereiralab.com/
We’re excited to share that our recent paper, “A combinatorial transcription factor screening platform for immune cell reprogramming”, has been selected for the cover of the January issue of Cell Systems!✨
January 21, 2026 at 5:16 PM
We’re excited to share that our recent paper, “A combinatorial transcription factor screening platform for immune cell reprogramming”, has been selected for the cover of the January issue of Cell Systems!✨
Reposted by Pereira Lab
New from @cellreprolab.bsky.social! The REPROcode library is a collection of over 400 immune-related human transcription factors in barcoded lenti vectors. Explore the set and find your favorite or mix-and-match: www.addgene.org/browse/artic...
January 14, 2026 at 9:35 PM
New from @cellreprolab.bsky.social! The REPROcode library is a collection of over 400 immune-related human transcription factors in barcoded lenti vectors. Explore the set and find your favorite or mix-and-match: www.addgene.org/browse/artic...
📢 New study from out lab published in @CellSystemsCP: REPROcode — a combinatorial single-cell screening platform to discover the transcription-factor (TF) recipes that reprogram immune cells.
Read it here: www.sciencedirect.com/science/arti...
Read it here: www.sciencedirect.com/science/arti...
A combinatorial transcription factor screening platform for immune cell reprogramming
Direct reprogramming of immune cells holds promise for immunotherapy but is constrained by limited knowledge of transcription factor (TF) networks. He…
www.sciencedirect.com
January 14, 2026 at 4:37 PM
📢 New study from out lab published in @CellSystemsCP: REPROcode — a combinatorial single-cell screening platform to discover the transcription-factor (TF) recipes that reprogram immune cells.
Read it here: www.sciencedirect.com/science/arti...
Read it here: www.sciencedirect.com/science/arti...
1/3 It’s an honor to share that our lab was awarded a Discovery grant from the American Brain Tumor Association (ABTA) for the project “In vivo Dendritic Cell Reprogramming as a New Immunotherapy for Glioblastoma”. @theabta.bsky.social
October 29, 2025 at 11:14 AM
1/3 It’s an honor to share that our lab was awarded a Discovery grant from the American Brain Tumor Association (ABTA) for the project “In vivo Dendritic Cell Reprogramming as a New Immunotherapy for Glioblastoma”. @theabta.bsky.social
1/4 Great to share that our lab was awarded a research grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development for the project “Advancing Reactive Tumor-Infiltrating Lymphocyte Therapy with Cellular Reprogramming”.
October 24, 2025 at 2:47 PM
1/4 Great to share that our lab was awarded a research grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development for the project “Advancing Reactive Tumor-Infiltrating Lymphocyte Therapy with Cellular Reprogramming”.
1/2 Sharing exciting news! ✨
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
October 14, 2025 at 3:41 PM
1/2 Sharing exciting news! ✨
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
1/3 Congrats to our team member @Peng Wei, who was awarded a SciLifeLab PULSE Postdoctoral Fellowship for his project SMARD, which will develop small molecule (SM)-assisted reprogramming to type 1 conventional dendritic cells (cDC1)!
For more info see: pereiralab.com/lab-news/pen...
For more info see: pereiralab.com/lab-news/pen...
Peng Wei Awarded a SciLifeLab PULSE Postdoctoral Fellowship - Pereira Lab
The researcher Peng Wei from Pereira Lab was awarded a SciLifeLab PULSE Postdoctoral Fellowship for the project SMARD—Small Molecule-Assisted Cell Reprogramming to cDC1. The SciLifeLab PULSE is a comp...
pereiralab.com
September 24, 2025 at 12:40 PM
1/3 Congrats to our team member @Peng Wei, who was awarded a SciLifeLab PULSE Postdoctoral Fellowship for his project SMARD, which will develop small molecule (SM)-assisted reprogramming to type 1 conventional dendritic cells (cDC1)!
For more info see: pereiralab.com/lab-news/pen...
For more info see: pereiralab.com/lab-news/pen...
1/2 Celebrating a double win!✨ Yesterday, at the Lund Stem Cell Center (LSCC) retreat, Ervin Ascic was awarded the Article of the Year Award with our Science paper "In vivo dendritic cell reprogramming for cancer immunotherapy" (www.science.org/doi/10.1126/...)
September 17, 2025 at 1:06 PM
1/2 Celebrating a double win!✨ Yesterday, at the Lund Stem Cell Center (LSCC) retreat, Ervin Ascic was awarded the Article of the Year Award with our Science paper "In vivo dendritic cell reprogramming for cancer immunotherapy" (www.science.org/doi/10.1126/...)
1/3 Call for Authors!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
September 8, 2025 at 11:08 AM
1/3 Call for Authors!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are proud to announce that Ervin Ascic successfully defended his PhD yesterday – with the special honor of Nobel Laureate James Allison as opponent! ✨
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
September 5, 2025 at 8:29 AM
We are proud to announce that Ervin Ascic successfully defended his PhD yesterday – with the special honor of Nobel Laureate James Allison as opponent! ✨
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
📢 New in @ImmunityCP: We have mapped the transcription factor “routes” that program two dendritic cell subsets opening paths for personalized #cancer #immunotherapy. Read it here: doi.org/10.1016/j.im...
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
August 29, 2025 at 4:11 PM
📢 New in @ImmunityCP: We have mapped the transcription factor “routes” that program two dendritic cell subsets opening paths for personalized #cancer #immunotherapy. Read it here: doi.org/10.1016/j.im...
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
1/6 Congrats to Margarida Brás and Daniel Oliveira that were awarded with PhD studentships from the Foundation for Science and Technology (FCT).
August 18, 2025 at 8:49 AM
1/6 Congrats to Margarida Brás and Daniel Oliveira that were awarded with PhD studentships from the Foundation for Science and Technology (FCT).
1/3 Our most recent protocol paper, “Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells”, is out in JoVE! @JoVEJournal
August 11, 2025 at 2:02 PM
1/3 Our most recent protocol paper, “Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells”, is out in JoVE! @JoVEJournal
Doubly proud! 🎉
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
August 3, 2025 at 1:53 PM
Doubly proud! 🎉
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
1/3 Glad to share that the work of our Postdoctoral Fellow Sandhya Malla @mal71056 secured funding from the Hanseatic Life Science Research Infrastructure Consortium (HALRIC) to study the mechanisms of dendritic cell reprogramming!
August 3, 2025 at 1:53 PM
1/3 Glad to share that the work of our Postdoctoral Fellow Sandhya Malla @mal71056 secured funding from the Hanseatic Life Science Research Infrastructure Consortium (HALRIC) to study the mechanisms of dendritic cell reprogramming!
1/3 Congrats to our team member Hugo Couto Moreira, who was awarded a Doctoral INPhINIT Retaining Fellowship from “la Caixa” Foundation to develop his PhD project “Reprogramming Regulatory T-cells”! @FundlaCaixa
August 3, 2025 at 1:52 PM
1/3 Congrats to our team member Hugo Couto Moreira, who was awarded a Doctoral INPhINIT Retaining Fellowship from “la Caixa” Foundation to develop his PhD project “Reprogramming Regulatory T-cells”! @FundlaCaixa
It’s an honor to share that our lab was awarded a Clinic & Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI) for the project “Engineering Synthetic Tertiary Lymphoid Structures in Melanoma with Dendritic Cell Reprogramming”. @CancerResearch
August 3, 2025 at 1:52 PM
It’s an honor to share that our lab was awarded a Clinic & Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI) for the project “Engineering Synthetic Tertiary Lymphoid Structures in Melanoma with Dendritic Cell Reprogramming”. @CancerResearch
1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl
August 3, 2025 at 1:52 PM
1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl
1/2 Congrats to our PhD student @ervin_ascic for winning the best poster award in “Improving Immunity” at the 22nd #CIMT Annual Meeting, Europe's Cancer Immunotherapy Meeting, held this year in Mainz, Germany. His work was regarded as an interesting, state-of-the-art technology.
August 3, 2025 at 1:51 PM
1/2 Congrats to our PhD student @ervin_ascic for winning the best poster award in “Improving Immunity” at the 22nd #CIMT Annual Meeting, Europe's Cancer Immunotherapy Meeting, held this year in Mainz, Germany. His work was regarded as an interesting, state-of-the-art technology.
1/3 We are excited to announce that the project Repro-TIL, standing for “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming”, was awarded a EIC Transition grant! @EUeic
August 3, 2025 at 1:51 PM
1/3 We are excited to announce that the project Repro-TIL, standing for “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming”, was awarded a EIC Transition grant! @EUeic
I am excited to share that I will presenting the latest advances in in vivo reprogramming for cancer immunotherapy at the Science Spotlight session during the #ISSCR2025 Annual Meeting in Hong Kong, June 11-14, 2025.
August 3, 2025 at 1:51 PM
I am excited to share that I will presenting the latest advances in in vivo reprogramming for cancer immunotherapy at the Science Spotlight session during the #ISSCR2025 Annual Meeting in Hong Kong, June 11-14, 2025.
1/4 Celebrating our collaborative efforts, highlighted in the paper “RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen presenting cells”, recently published in @PNASNews.
August 3, 2025 at 1:51 PM
1/4 Celebrating our collaborative efforts, highlighted in the paper “RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen presenting cells”, recently published in @PNASNews.
We recently had a great get-together joining the Pereira Lab and @AsgardThx, in an Interaction Day where all members shared their paths and aspirations.
What a magnificent way to share a day with our teammates! ✨
What a magnificent way to share a day with our teammates! ✨
August 3, 2025 at 1:51 PM
We recently had a great get-together joining the Pereira Lab and @AsgardThx, in an Interaction Day where all members shared their paths and aspirations.
What a magnificent way to share a day with our teammates! ✨
What a magnificent way to share a day with our teammates! ✨
1/3 Congrats to our team member Camille Chatelain who was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. Her project will advance a strategy for cancer therapy with tumor-reactive T cells! @MSCActions
August 3, 2025 at 1:50 PM
1/3 Congrats to our team member Camille Chatelain who was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. Her project will advance a strategy for cancer therapy with tumor-reactive T cells! @MSCActions
1/2 I am proud to announce that I will join the SciLifeLab community as a Group Leader! @scilifelab is a health and environmental infrastructure that fosters a solid web of researchers collaborating within sectors such as industry and health care.
Read 👇
Read 👇
August 3, 2025 at 1:50 PM
1/2 I am proud to announce that I will join the SciLifeLab community as a Group Leader! @scilifelab is a health and environmental infrastructure that fosters a solid web of researchers collaborating within sectors such as industry and health care.
Read 👇
Read 👇